United States Pharmaceuticals

Corium International Inc (CORI)

Track

Track

Ticker: CORI Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Gurnet Holding Co Large shareholder
Transaction date
Purchase
Price
167.69
Quantity 75,154 -20.0%
Value US$3,570,804
Gurnet Holding Co Large shareholder
Transaction date
Purchase
Price
93.11
Quantity 43,181 -10.4%
Value US$1,212,741
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Sale
Price
427.78
Quantity 22,220 -2.9%
Value US$3,322,340
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Sale
Price
12.51
Quantity 500,000 -9.0%
Value US$6,255,000
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Sale
Price
12.50
Quantity 500,000 -8.2%
Value US$6,250,000
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Sale
Price
12.51
Quantity 282,447 -4.4%
Value US$3,533,412
Sweemer Timothy D Chief Accounting Officer Officer
Transaction date
Sale
Price
9.01
Quantity 346 -1.0%
Value US$3,117
Singh Parminder CTO & Vice President, R&D Officer
Transaction date
Sale
Price
9.01
Quantity 3,133 -16.5%
Value US$28,224
BREUIL ROBERT S Chief Financial Officer Officer
Transaction date
Sale
Price
9.01
Quantity 972 -6.3%
Value US$8,756
Sarret Joseph J. Chief Business Officer Officer
Transaction date
Sale
Price
9.01
Quantity 3,565 -18.0%
Value US$32,116
STAPLE PETER D President & CEO Executive Director
Transaction date
Planned sale
Price
8.96
Quantity 34,320 -12.2%
Value US$307,586
STAPLE PETER D President & CEO Executive Director
Transaction date
Sale
Price
9.01
Quantity 2,701 -0.9%
Value US$24,332
STAPLE PETER D President & CEO Executive Director
Transaction date
Planned sale
Price
8.66
Quantity 39,320 -12.4%
Value US$340,606
Thomas Robert Non-Executive Director
Transaction date
Planned sale
Price
8.86
Quantity 35,608 -100.0%
Value US$315,476
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Purchase
Price
12.80
Quantity 310,000 +5.1%
Value US$3,968,000
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Purchase
Price
12.24
Quantity 149,650 +2.5%
Value US$1,831,716
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Purchase
Price
11.83
Quantity 50,350 +0.9%
Value US$595,640
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Sale
Price
10.95
Quantity 25,000 -0.7%
Value US$273,750
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Sale
Price
10.96
Quantity 9,255 -0.3%
Value US$101,435
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Sale
Price
10.95
Quantity 100,000 -2.7%
Value US$1,095,000
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Sale
Price
11.01
Quantity 65,345 -1.7%
Value US$719,448
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Sale
Price
10.97
Quantity 400 -0.0%
Value US$4,388
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Sale
Price
10.88
Quantity 25,000 -0.7%
Value US$272,000
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Sale
Price
10.85
Quantity 25,000 -0.7%
Value US$271,250
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Sale
Price
10.97
Quantity 250,000 -6.1%
Value US$2,742,500
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Sale
Price
11.05
Quantity 150,000 -3.6%
Value US$1,657,500
Broadfin Healthcare Master Fund Ltd Large shareholder
Transaction date
Sale
Price
11.01
Quantity 218,100 -4.9%
Value US$2,401,107
Singh Parminder CTO & Vice President, R&D
Transaction date
Sale
Price
7.61
Quantity 22,822 -74.2%
Value US$173,561
Singh Parminder CTO & Vice President, R&D
Transaction date
Sale
Price
7.53
Quantity 7,593 -19.8%
Value US$57,139
Sweemer Timothy D Chief Accounting Officer
Transaction date
Sale
Price
7.62
Quantity 12,012 -27.1%
Value US$91,529
Singh Parminder CTO & Vice President, R&D
Transaction date
Sale
Price
7.61
Quantity 32,000 -45.5%
Value US$243,619
Sweemer Timothy D Chief Accounting Officer
Transaction date
Sale
Price
7.82
Quantity 15,488 -25.9%
Value US$121,156
Sarret Joseph J. Chief Business Officer Officer
Transaction date
Planned sale
Price
8.95
Quantity 2,038 -21.5%
Value US$18,232
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Purchase
Price
7.71
Quantity 301,004 +5.4%
Value US$2,319,236
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Purchase
Price
6.25
Quantity 1,902,400 +52.2%
Value US$11,890,000
BJERKHOLT ERIC Non-Executive Director
Transaction date
Purchase
Price
3.70
Quantity 6,341 +112.1%
Value US$23,453
BJERKHOLT ERIC Non-Executive Director
Transaction date
Purchase
Price
3.71
Quantity 7,790 +165.4%
Value US$28,879
BJERKHOLT ERIC Non-Executive Director
Transaction date
Purchase
Price
3.57
Quantity 5,659 +inf%
Value US$20,179
BJERKHOLT ERIC Non-Executive Director
Transaction date
Purchase
Price
3.54
Quantity 4,710 +inf%
Value US$16,688
STAPLE PETER D President & CEO Executive Director
Transaction date
Purchase
Price
3.70
Quantity 6,500 +22.9%
Value US$24,046
STAPLE PETER D President & CEO Executive Director
Transaction date
Purchase
Price
3.50
Quantity 6,000 +26.8%
Value US$20,996
GREENWOOD DAVID Non-Executive Director
Transaction date
Purchase
Price
3.58
Quantity 3,000 +inf%
Value US$10,742
STAPLE PETER D President & CEO Executive Director
Transaction date
Purchase
Price
6.99
Quantity 3,600 +19.2%
Value US$25,169
BREUIL ROBERT S Chief Financial Officer Officer
Transaction date
Purchase
Price
5.40
Quantity 1,600 +40.0%
Value US$8,640
STAPLE PETER D President & CEO Executive Director
Transaction date
Purchase
Price
5.34
Quantity 9,000 +92.0%
Value US$48,055
STAPLE PETER D President & CEO Executive Director
Transaction date
Purchase
Price
6.20
Quantity 300 +3.2%
Value US$1,860
STAPLE PETER D President & CEO Executive Director
Transaction date
Purchase
Price
6.14
Quantity 1,000 +11.8%
Value US$6,144
STAPLE PETER D President & CEO Executive Director
Transaction date
Purchase
Price
6.05
Quantity 1,278 +17.8%
Value US$7,726
STAPLE PETER D President & CEO Executive Director
Transaction date
Purchase
Price
7.08
Quantity 2,400 +50.0%
Value US$16,982
STAPLE PETER D President & CEO Executive Director
Transaction date
Purchase
Price
7.08
Quantity 2,900 +152.6%
Value US$20,518
STAPLE PETER D President & CEO Executive Director
Transaction date
Purchase
Price
6.95
Quantity 1,900 +inf%
Value US$13,206
ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
Transaction date
Purchase
Price
8.00
Quantity 400,000 +4.5%
Value US$3,200,000
Eastman Ronald W Non-Executive Director Large shareholder
Transaction date
Purchase
Price
8.00
Quantity 400,000 +4.5%
Value US$3,200,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2018-11-28 2018-11-27 B Purchase Gurnet Holding Co Large shareholder
75,154 -20.0%
167.69
US$3,570,804 		75,154 -20.0% 167.69 US$3,570,804
2018-11-28 2018-11-27 B Purchase Gurnet Holding Co Large shareholder
43,181 -10.4%
93.11
US$1,212,741 		43,181 -10.4% 93.11 US$1,212,741
2018-10-15 2018-10-12 S Sale PERCEPTIVE ADVISORS LLC Large shareholder
22,220 -2.9%
427.78
US$3,322,340 		22,220 -2.9% 427.78 US$3,322,340
2018-10-15 2018-10-12 S Sale PERCEPTIVE ADVISORS LLC Large shareholder
500,000 -9.0%
12.51
US$6,255,000 		500,000 -9.0% 12.51 US$6,255,000
2018-10-15 2018-10-11 S Sale PERCEPTIVE ADVISORS LLC Large shareholder
500,000 -8.2%
12.50
US$6,250,000 		500,000 -8.2% 12.50 US$6,250,000
2018-10-15 2018-10-11 S Sale PERCEPTIVE ADVISORS LLC Large shareholder
282,447 -4.4%
12.51
US$3,533,412 		282,447 -4.4% 12.51 US$3,533,412
2018-08-17 2018-08-17 S Sale Sweemer Timothy D

Chief Accounting Officer

Officer
346 -1.0%
9.01
US$3,117 		346 -1.0% 9.01 US$3,117
2018-08-17 2018-08-17 S Sale Singh Parminder

CTO & Vice President, R&D

Officer
3,133 -16.5%
9.01
US$28,224 		3,133 -16.5% 9.01 US$28,224
2018-08-17 2018-08-17 S Sale BREUIL ROBERT S

Chief Financial Officer

Officer
972 -6.3%
9.01
US$8,756 		972 -6.3% 9.01 US$8,756
2018-08-17 2018-08-17 S Sale Sarret Joseph J.

Chief Business Officer

Officer
3,565 -18.0%
9.01
US$32,116 		3,565 -18.0% 9.01 US$32,116
2018-08-17 2018-08-17 PlS Planned sale STAPLE PETER D

President & CEO

Executive Director
34,320 -12.2%
8.96
US$307,586 		34,320 -12.2% 8.96 US$307,586
2018-08-17 2018-08-17 S Sale STAPLE PETER D

President & CEO

Executive Director
2,701 -0.9%
9.01
US$24,332 		2,701 -0.9% 9.01 US$24,332
2018-08-17 2018-08-16 PlS Planned sale STAPLE PETER D

President & CEO

Executive Director
39,320 -12.4%
8.66
US$340,606 		39,320 -12.4% 8.66 US$340,606
2018-08-17 2018-08-15 PlS Planned sale Thomas Robert Non-Executive Director
35,608 -100.0%
8.86
US$315,476 		35,608 -100.0% 8.86 US$315,476
2018-01-18 2018-01-18 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
310,000 +5.1%
12.80
US$3,968,000 		310,000 +5.1% 12.80 US$3,968,000
2018-01-18 2018-01-17 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
149,650 +2.5%
12.24
US$1,831,716 		149,650 +2.5% 12.24 US$1,831,716
2018-01-18 2018-01-16 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
50,350 +0.9%
11.83
US$595,640 		50,350 +0.9% 11.83 US$595,640
2017-11-17 2017-11-17 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
25,000 -0.7%
10.95
US$273,750 		25,000 -0.7% 10.95 US$273,750
2017-11-17 2017-11-17 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
9,255 -0.3%
10.96
US$101,435 		9,255 -0.3% 10.96 US$101,435
2017-11-17 2017-11-17 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
100,000 -2.7%
10.95
US$1,095,000 		100,000 -2.7% 10.95 US$1,095,000
2017-11-17 2017-11-17 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
65,345 -1.7%
11.01
US$719,448 		65,345 -1.7% 11.01 US$719,448
2017-11-17 2017-11-16 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
400 -0.0%
10.97
US$4,388 		400 -0.0% 10.97 US$4,388
2017-11-17 2017-11-16 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
25,000 -0.7%
10.88
US$272,000 		25,000 -0.7% 10.88 US$272,000
2017-11-17 2017-11-16 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
25,000 -0.7%
10.85
US$271,250 		25,000 -0.7% 10.85 US$271,250
2017-11-17 2017-11-16 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
250,000 -6.1%
10.97
US$2,742,500 		250,000 -6.1% 10.97 US$2,742,500
2017-11-03 2017-11-02 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
150,000 -3.6%
11.05
US$1,657,500 		150,000 -3.6% 11.05 US$1,657,500
2017-10-06 2017-10-04 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
218,100 -4.9%
11.01
US$2,401,107 		218,100 -4.9% 11.01 US$2,401,107
2017-08-23 2017-08-22 S Sale Singh Parminder

CTO & Vice President, R&D
22,822 -74.2%
7.61
US$173,561 		22,822 -74.2% 7.61 US$173,561
2017-08-23 2017-08-21 S Sale Singh Parminder

CTO & Vice President, R&D
7,593 -19.8%
7.53
US$57,139 		7,593 -19.8% 7.53 US$57,139
2017-08-18 2017-08-17 S Sale Sweemer Timothy D

Chief Accounting Officer
12,012 -27.1%
7.62
US$91,529 		12,012 -27.1% 7.62 US$91,529
2017-08-18 2017-08-17 S Sale Singh Parminder

CTO & Vice President, R&D
32,000 -45.5%
7.61
US$243,619 		32,000 -45.5% 7.61 US$243,619
2017-08-18 2017-08-16 S Sale Sweemer Timothy D

Chief Accounting Officer
15,488 -25.9%
7.82
US$121,156 		15,488 -25.9% 7.82 US$121,156
2017-07-21 2017-07-20 PlS Planned sale Sarret Joseph J.

Chief Business Officer

Officer
2,038 -21.5%
8.95
US$18,232 		2,038 -21.5% 8.95 US$18,232
2017-07-05 2017-06-30 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
301,004 +5.4%
7.71
US$2,319,236 		301,004 +5.4% 7.71 US$2,319,236
2017-05-25 2017-05-25 B Purchase PERCEPTIVE ADVISORS LLC Large shareholder
1,902,400 +52.2%
6.25
US$11,890,000 		1,902,400 +52.2% 6.25 US$11,890,000
2016-05-20 2016-05-19 B Purchase BJERKHOLT ERIC Non-Executive Director
6,341 +112.1%
3.70
US$23,453 		6,341 +112.1% 3.70 US$23,453
2016-05-20 2016-05-19 B Purchase BJERKHOLT ERIC Non-Executive Director
7,790 +165.4%
3.71
US$28,879 		7,790 +165.4% 3.71 US$28,879
2016-05-20 2016-05-18 B Purchase BJERKHOLT ERIC Non-Executive Director
5,659 +inf%
3.57
US$20,179 		5,659 +inf% 3.57 US$20,179
2016-05-20 2016-05-18 B Purchase BJERKHOLT ERIC Non-Executive Director
4,710 +inf%
3.54
US$16,688 		4,710 +inf% 3.54 US$16,688
2016-05-17 2016-05-16 B Purchase STAPLE PETER D

President & CEO

Executive Director
6,500 +22.9%
3.70
US$24,046 		6,500 +22.9% 3.70 US$24,046
2016-05-17 2016-05-13 B Purchase STAPLE PETER D

President & CEO

Executive Director
6,000 +26.8%
3.50
US$20,996 		6,000 +26.8% 3.50 US$20,996
2016-05-16 2016-05-12 B Purchase GREENWOOD DAVID Non-Executive Director
3,000 +inf%
3.58
US$10,742 		3,000 +inf% 3.58 US$10,742
2015-02-26 2015-02-25 B Purchase STAPLE PETER D

President & CEO

Executive Director
3,600 +19.2%
6.99
US$25,169 		3,600 +19.2% 6.99 US$25,169
2014-11-24 2014-11-24 B Purchase BREUIL ROBERT S

Chief Financial Officer

Officer
1,600 +40.0%
5.40
US$8,640 		1,600 +40.0% 5.40 US$8,640
2014-11-24 2014-11-21 B Purchase STAPLE PETER D

President & CEO

Executive Director
9,000 +92.0%
5.34
US$48,055 		9,000 +92.0% 5.34 US$48,055
2014-08-27 2014-08-27 B Purchase STAPLE PETER D

President & CEO

Executive Director
300 +3.2%
6.20
US$1,860 		300 +3.2% 6.20 US$1,860
2014-08-27 2014-08-26 B Purchase STAPLE PETER D

President & CEO

Executive Director
1,000 +11.8%
6.14
US$6,144 		1,000 +11.8% 6.14 US$6,144
2014-08-27 2014-08-25 B Purchase STAPLE PETER D

President & CEO

Executive Director
1,278 +17.8%
6.05
US$7,726 		1,278 +17.8% 6.05 US$7,726
2014-05-30 2014-05-30 B Purchase STAPLE PETER D

President & CEO

Executive Director
2,400 +50.0%
7.08
US$16,982 		2,400 +50.0% 7.08 US$16,982
2014-05-30 2014-05-29 B Purchase STAPLE PETER D

President & CEO

Executive Director
2,900 +152.6%
7.08
US$20,518 		2,900 +152.6% 7.08 US$20,518
2014-05-30 2014-05-28 B Purchase STAPLE PETER D

President & CEO

Executive Director
1,900 +inf%
6.95
US$13,206 		1,900 +inf% 6.95 US$13,206
2014-04-08 2014-04-08 B Purchase ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
400,000 +4.5%
8.00
US$3,200,000 		400,000 +4.5% 8.00 US$3,200,000
2014-04-08 2014-04-08 B Purchase Eastman Ronald W Non-Executive Director Large shareholder
400,000 +4.5%
8.00
US$3,200,000 		400,000 +4.5% 8.00 US$3,200,000
Explore more

More insider trading research around Corium International Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America